1Furchgott RF. Endothelium-derived relaxing factor: discovery,early studies, and identification as nitric oxide. Biosci Rep,1999, 19(4): 235-251.
2Wang XL, Wang J. Endothelial nitric oxide synthase gene sequence variations and vascular disease. Mol Genet Metab, 2000, 70(4):241-251.
3Tesauro M, Thompson WC, Rogliani P, et al. Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc Natl Acad Sci USA, 2000, 97(6): 2832-2835.
4Jachymova M, Horky K, Bultas J, et al. Association of the Glu298Asp polymorphism in the endothelial nitric oxide synthase gene with essential hypertension resistant to conventional therapy.Biochem Biophys Res Commun, 2001, 284(2): 426-430.
5Wolff B, Grahe HJ, Schluter C, et al. Endothelial nitric oxide synthase Glu298Asp gene polymorphism, blood pressure and hypertension in a general population sample. J Hypertens, 2005, 23 (7):1361-1366.
6Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med, 2005, 352(15):1585-1695.
7Yoon S, Shin C, Park HY, et al. Endothelial nitric oxide synthase gene is associated with vessel stenosis in Korean population. Clin Chim Acta, 2005, 353(1-2): 177-185.
8Colombo MG, Paradossi U, Andreassi MG, et al. Endothelial nitric oxide synthsse gcne polymorphisms and risk of coronary artery disease. Clin Chem, 2003, 49(3): 389-395.
9Gorchakova O, Koch W, von-Beckerath N, et al. Association of a genetic variant of endothelial nitric oxide synthase with the 1 year clinical outcome after coronary stent placement. Eur Heart J,2003, 24(9): 820-827.
10Park KW, You KH, Oh S, et al. Association of endothelial constitutive nitric oxide synthase gene polymorphism with acute coronary syndrome in Koreans. Heart, 2004, 90(3): 282-285.
